Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combinations of a mithramycin analogue and another chemotherapeutic agent for the treatment of triple negative breast cancer

Combinations of a mithramycin analogue and another chemotherapeutic agent for the treatment of triple negative breast cancer

US Patent 10568899 · Granted Feb 25, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antitumor activity of multi-kinase inhibitors in colorectal cancer2019
Antitumor activity of multi-kinase inhibitors in colorectal cancer2019
Antitumor activity of multi-kinase inhibitors in colorectal cancer2019
Antitumor activity of multi-kinase inhibitors in triple negative breast cancer2017
Antitumor activity of multi-kinase inhibitors in triple negative breast cancer2017
Antitumor activity of multi-kinase inhibitors in triple negative breast cancer2017
Process for the enzymatic synthesis of (7S)-1-(3,4-dimethoxybicyclo[4.2.0]octa-12015
Aureolic acid derivatives, the method for preparation thereof and the uses2014
Glycosylated indolocarbazoles, method for obtaining same and uses thereof2013